Senti Biosciences, Inc.

Dynamics Special Purpose Corp, trading under the ticker DYNS, was a blank-check company that completed its initial public offering in 2021 with a focus on the life sciences and biotechnology sector. Sponsored by Dynamics Special Purpose LLC, the vehicle targeted companies operating at the intersection of technology and biology. DYNS entered into a business combination agreement with Senti Biosciences, Inc., a synthetic biology company developing gene circuit technology for cell and gene therapies. The 10-Q filed on May 16, 2022, under accession number 0001193125-22-151676, reflects the company's financial position during the de-SPAC transition period ahead of the merger closing. Sign up at SpacDesk for complete filing history, sponsor profiles, and real-time deal status tracking on DYNS and hundreds of other SPAC transactions.